Table 1. Clinical course and dosing... | American Society of Hematology

Table 1.

Clinical course and dosing adjustment

Date	12/13/1999	1/5/2001	3/30/2001	5/10/2001	6/11/2001	7/9/2001	9/10/2001	10/31/2001	1/2/2002
M-protein g/dL	5.2	2.72	3.07	3.45	2.79	2.47	1.93	1.89	1.78
Thalidomide mg/d	400	300	NT	Starting 100	100	100	100	100	100

Date	12/13/1999	1/5/2001	3/30/2001	5/10/2001	6/11/2001	7/9/2001	9/10/2001	10/31/2001	1/2/2002
M-protein g/dL	5.2	2.72	3.07	3.45	2.79	2.47	1.93	1.89	1.78
Thalidomide mg/d	400	300	NT	Starting 100	100	100	100	100	100

NT indicates no treatment.